TRPV4 and melanoma: Interestingly, 2-APB application dominated A2058 cells undergoing necrosis and late apoptosis other than early apoptosis both via FITC-Annexin V/PI staining and Hochest33342/PI staining (Figure 7(b)), which was clearly different from the activation of TRPV4 in melanoma A375 cells.